bioRxivBioengineering
The TrkA agonist gambogic amide augments skeletal adaptation to mechanical loading through actions on sensory nerves and osteoblasts
Abstract
The periosteal and endosteal surfaces of mature bone are densely innervated by sensory nerves expressing TrkA, the high-affinity receptor for nerve growth factor (NGF). In previous work, we demonstrated that administration of exogenous NGF significantly increased load-induced bone formation through the activation of Wnt signaling. However, the translational potential of NGF is limited by the induction of substantial mechanical and thermal hyperalgesia in mice and humans. Here, we tested the effect of gambogic amide (GA), a recently identified robust small molecule agonist for TrkA, on hyperalgesia and load-induced bone formation. Behavioral analysis was used to assess pain up to one week after axial forelimb compression. Contrary to our expectations, GA treatment was not associated with diminished use of the loaded forelimb or sensitivity to thermal stimulus. Furthermore, dynamic histomorphometry revealed a significant increase in relative periosteal bone formation rate as compared to vehicle treatment. Additionally, we found that GA treatment was associated with an increase in the number of osteoblasts per bone surface in loaded limbs as well as a significant upregulation of Wnt1, Wnt7b, and Ngf in loaded bones. To determine if these effects were exclusively mediated by NGF-TrkA signaling in sensory nerves, we cultured MC3T3-E1 cells for 7 or 14 days in osteogenic differentiation media containing NGF (50 ng/mL), GA (5, 50, or 500 nM), or vehicle (DMSO). After 7 days of culture, we observed increases in osteoblastic differentiation markers Runx2, Bglap2, and Sp7 in response to GA, whereas treatment with NGF was not different than vehicle. Only cells treated with the highest dose of GA (500 nM) had significantly impaired cell proliferation. In conclusion, our study indicates GA may be useful for augmenting skeletal adaptation to mechanical forces without inducing hyperalgesia through actions on both sensory nerves and osteoblasts.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Osteoblast-derived Nerve Growth Factor is Required for Skeletal Adaptation to Mechanical Load and the Osteoanabolic Effect of Gambogic Amide in Mice
Ibtesam Rajpar, Eric McLaughlin, … Ryan E. Tomlinson·bioRxiv·Jul 8, 2025
- Toll-like receptor 4 signaling in osteoblasts is required for load-induced bone formation in mice
I. Rajpar, G. Kumar, … R. E. Tomlinson·bioRxiv·Aug 5, 2022
- A painless nerve growth factor variant uncouples nociceptive and neurotrophic TrkA signaling
Shailesh Kumar, Harry Jung, … Moitrayee Bhattacharyya·bioRxiv·Nov 18, 2025
- Designed NGF mimetics with reduced nociceptive signatures in neurons
Thomas Schlichthaerle, Aerin Yang, … David A. Baker·bioRxiv·Apr 14, 2025
- Structural basis for direct NGF/TrkA blockade by an analgesic antibody
Harsh Bansia, Elisa Damo, … Amédée des Georges·bioRxiv·Jul 1, 2026
- Swedish Nerve Growth Factor Mutation (NGFR100W) Defines a Role for TrkA and p75NTR in Nociception
Kijung Sung, Luiz F. Ferrari, … Chengbiao Wu·Journal of NeurosciencePeer-reviewed·Feb 26, 2018